[Correction of metabolic disturbances in patients with cholestasis].
The nosologic and etiopathogenetic structure of the cholestatic syndrome encountered both in surgical and therapeutical practice is described.
Rodonezhskaia
E V
EV
Kharchenko
N V
NV
D000469:Alkaline Phosphatase / Q000097:blood; D001663:Bilirubin / Q000097:blood; D002756:Cholagogues and Choleretics / Q000627:therapeutic use; D002779:Cholestasis / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism*; D002784:Cholesterol / Q000097:blood; D019694:Hepatitis B, Chronic / Q000150:complications / Q000378:metabolism*; D006519:Hepatitis, Alcoholic / Q000150:complications / Q000378:metabolism*; D006801:Humans; D008074:Lipoproteins / Q000097:blood; D008105:Liver Cirrhosis, Biliary / Q000150:complications / Q000378:metabolism*; D010634:Phenobarbital / Q000627:therapeutic use; D010743:Phospholipids / Q000097:blood; D014280:Triglycerides / Q000097:blood; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use; D005723:gamma-Glutamyltransferase / Q000097:blood
D002756:Cholagogues and Choleretics; D008074:Lipoproteins; D010743:Phospholipids; D014280:Triglycerides; D014580:Ursodeoxycholic Acid; D002784:Cholesterol; D005723:gamma-Glutamyltransferase; D000469:Alkaline Phosphatase; D001663:Bilirubin; D010634:Phenobarbital